Reply to: "Bleeding Risk and Management in Interventional Procedures in Chronic Liver Disease"

J Vasc Interv Radiol. 2017 Jun;28(6):922-923. doi: 10.1016/j.jvir.2017.04.001.

Authors

Gia A DeAngelis¹, Rachita Khot¹, Ziv J Haskal¹, Hillary S Maitland², Patrick G Northup³, Neeral L Shah³, Stephen H Caldwell³

Affiliations

¹ Department of Radiology and Medical Imaging, Division of Hematology/Oncology, University of Virginia Health System, Box 800170, Charlottesville, VA 22908.
² Department of Medicine, University of Virginia Health System, Box 800170, Charlottesville, VA 22908.
³ Coagulation in Liver Disease Study Group Division of Gastroenterology and Hepatology Department of Medicine, University of Virginia Health System, Box 800170, Charlottesville, VA 22908.

PMID: 28532752
DOI: 10.1016/j.jvir.2017.04.001

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticoagulants*
Humans
Liver Diseases*

Substances

Anticoagulants